Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-05-01
|
Series: | JID Innovations |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026722000108 |
_version_ | 1811258089282732032 |
---|---|
author | Marjan Azin Andrew B. Mahon Steven Isaacman Julia E. Seaman Isabel E. Allen Michael Szarek Lynn A. Cornelius Shadmehr Demehri |
author_facet | Marjan Azin Andrew B. Mahon Steven Isaacman Julia E. Seaman Isabel E. Allen Michael Szarek Lynn A. Cornelius Shadmehr Demehri |
author_sort | Marjan Azin |
collection | DOAJ |
first_indexed | 2024-04-12T18:08:50Z |
format | Article |
id | doaj.art-0ed6b915684f49cea61948ac8b259b9b |
institution | Directory Open Access Journal |
issn | 2667-0267 |
language | English |
last_indexed | 2024-04-12T18:08:50Z |
publishDate | 2022-05-01 |
publisher | Elsevier |
record_format | Article |
series | JID Innovations |
spelling | doaj.art-0ed6b915684f49cea61948ac8b259b9b2022-12-22T03:21:54ZengElsevierJID Innovations2667-02672022-05-0123100104Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis TreatmentMarjan Azin0Andrew B. Mahon1Steven Isaacman2Julia E. Seaman3Isabel E. Allen4Michael Szarek5Lynn A. Cornelius6Shadmehr Demehri7Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Immunology, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Research, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USAPHD Biosciences, San Diego, California, USAPHD Biosciences, San Diego, California, USABay View Analytics, Oakland, California, USABay View Analytics, Oakland, California, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USASchool of Public Health, SUNY Downstate Health Sciences University, Brooklyn, New York, USA; CPC Clinical Research, Aurora, Colorado, USA; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USADivision of Dermatology, John T. Milliken Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USACutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Immunology, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cancer Research, Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Corresponding authorhttp://www.sciencedirect.com/science/article/pii/S2667026722000108 |
spellingShingle | Marjan Azin Andrew B. Mahon Steven Isaacman Julia E. Seaman Isabel E. Allen Michael Szarek Lynn A. Cornelius Shadmehr Demehri Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment JID Innovations |
title | Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment |
title_full | Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment |
title_fullStr | Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment |
title_full_unstemmed | Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment |
title_short | Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment |
title_sort | topical calcipotriol plus 5 fluorouracil immunotherapy for actinic keratosis treatment |
url | http://www.sciencedirect.com/science/article/pii/S2667026722000108 |
work_keys_str_mv | AT marjanazin topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT andrewbmahon topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT stevenisaacman topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT juliaeseaman topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT isabeleallen topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT michaelszarek topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT lynnacornelius topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment AT shadmehrdemehri topicalcalcipotriolplus5fluorouracilimmunotherapyforactinickeratosistreatment |